All Comparisons/Glass Health vs Carta Healthcare

VNDRIQ — Vendor Comparison

Glass Health vs Carta Healthcare

Side-by-side comparison of BAA status, PHI exposure, AI training risk, HIPAA suitability, and VNDRIQ governance scores.

Glass Health30
Carta Healthcare82

Glass Health

Clinical Intelligence AI

Last verified: September 30, 2026

Carta Healthcare

Clinical Intelligence AI

Last verified: August 31, 2026

VNDRIQ Scores

30

Overall

Privacy Score23
Governance Score38
Healthcare Readiness36
AI Risk Score21

82

Overall

Privacy Score68
Governance Score85
Healthcare Readiness83
AI Risk Score90

Approval Tier

Restricted / Review Required
Approved

BAA Status

Verify Directly
Available upon request for healthcare clients

PHI Exposure Risk

Critical
Medium

AI Training Risk

High
Low

HIPAA Risk Level

High
Low

Review Frequency

Quarterly

Quarterly

Recommended Use

—

Clinical data abstraction, registry management, and clinical data analysis.

Restrictions

—

None specified, but requires standard BAA execution for PHI processing.

Executive Summary

Glass Health

Clinical Intelligence AI

Glass Health is classified as Restricted / Review Required with a BAA status of Verify Directly. PHI exposure is rated Critical and AI training risk is High.

23

Privacy

38

Governance

36

Healthcare

21

AI Risk

Carta Healthcare

Clinical Intelligence AI

Carta Healthcare is classified as Approved with a BAA status of Available upon request for healthcare clients. PHI exposure is rated Medium and AI training risk is Low. Clinical data abstraction, registry management, and clinical data analysis.

68

Privacy

85

Governance

83

Healthcare

90

AI Risk

Recommended For

Glass Health

Currently under review — not recommended for active PHI deployment

Carta Healthcare

Clinical data abstraction, registry management, and clinical data analysis.

Organizations with established governance workflows

Multi-location healthcare groups needing standardized vendor status

Governance Considerations

Glass Health

BAA has not been confirmed. Execute BAA before processing PHI.

Verify model training opt-out clauses before deployment.

PHI exposure is elevated. Review data flow documentation.

Quarterly reviews are required — establish internal review cadence.

Carta Healthcare

Quarterly reviews are required — establish internal review cadence.

Restrictions noted: None specified, but requires standard BAA execution for PHI processing.

Questions to Ask Before Approval

01

Has the vendor executed a Business Associate Agreement (BAA) with your organization?

02

Does the vendor use customer data to train AI models? Can you opt out?

03

Where is PHI stored, processed, and transmitted?

04

What data retention and deletion policies apply to your PHI?

05

Has the vendor undergone a third-party HIPAA or SOC 2 audit?

06

What is the vendor's incident response and breach notification process?

07

Does the vendor offer audit logging for PHI access?

08

What subprocessors have access to PHI through this vendor?

Request Vendor Evaluation

Get a structured risk assessment for any vendor.

Request Benchmark Report

Compare vendors across your full stack.

Book Governance Assessment

Talk to a VNDRIQ governance specialist.